BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8452106)

  • 1. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.
    Austin JP; Convery K
    Am J Clin Oncol; 1993 Apr; 16(2):140-5. PubMed ID: 8452106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
    Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
    JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
    Polednak AP; Flannery JT
    Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason's grading system.
    Aziz H; Rotman M; Thelmo W; Chen P; Choi KN; Khil SU; Laungani GB; Brandys M; Ayr G; Macchia RJ
    Am J Clin Oncol; 1988 Apr; 11(2):166-71. PubMed ID: 3358363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean Island immigrants.
    Hussain F; Aziz H; Macchia R; Avitable M; Rotman M
    Int J Radiat Oncol Biol Phys; 1992; 24(3):451-61. PubMed ID: 1399730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.
    Thatai LC; Banerjee M; Lai Z; Vaishampayan U
    Urology; 2004 Oct; 64(4):738-43. PubMed ID: 15491712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
    Halabi S; Small EJ; Vogelzang NJ; Barrier RC; George SL; Gilligan TD
    Urology; 2004 Aug; 64(2):212-7. PubMed ID: 15302462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.
    Pienta KJ; Demers R; Hoff M; Kau TY; Montie JE; Severson RK
    Urology; 1995 Jan; 45(1):93-101; discussion 101-2. PubMed ID: 7817485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished survival of young blacks with adenocarcinoma of the prostate.
    Austin JP; Aziz H; Potters L; Thelmo W; Chen P; Choi K; Brandys M; Macchia RJ; Rotman M
    Am J Clin Oncol; 1990 Dec; 13(6):465-9. PubMed ID: 2239799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?
    Streeter OE; Martz KL; Gaspar LE; Delrowe JD; Asbell SO; Salter MM; Roach M
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1047-52. PubMed ID: 10421537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and the histologic grade of prostate cancer.
    Freeman VL; Leszczak J; Cooper RS
    Prostate; 1997 Feb; 30(2):79-84. PubMed ID: 9051145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites.
    Levine RL; Wilchinsky M
    J Urol; 1979 Jun; 121(6):761-2. PubMed ID: 458946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
    Sherman ME; Devesa SS
    Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of age and race with hospital death after acute myocardial infarction.
    Manhapra A; Canto JG; Vaccarino V; Parsons L; Kiefe CI; Barron HV; Rogers WJ; Weaver WD; Borzak S
    Am Heart J; 2004 Jul; 148(1):92-8. PubMed ID: 15215797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects.
    Tyson MD; Castle EP
    Mayo Clin Proc; 2014 Mar; 89(3):300-7. PubMed ID: 24582189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS Scientific Renal Transplant Registry--2000.
    Cecka JM
    Clin Transpl; 2000; ():1-18. PubMed ID: 11512303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.
    Graham MV; Geitz LM; Byhardt R; Asbell S; Roach M; Urtasun RC; Curran WJ; Lattin P; Russell AH; Cox JD
    J Natl Cancer Inst; 1992 Nov; 84(22):1731-5. PubMed ID: 1331484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
    Powell IJ; Schwartz K; Hussain M
    Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in TKA Outcomes: Census Tract Data Show Interactions Between Race and Poverty.
    Goodman SM; Mandl LA; Parks ML; Zhang M; McHugh KR; Lee YY; Nguyen JT; Russell LA; Bogardus MH; Figgie MP; Bass AR
    Clin Orthop Relat Res; 2016 Sep; 474(9):1986-95. PubMed ID: 27278675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.